A Korean manufacturer of PNA (Peptide Nucleic Acid) technology-based mutation detection kits and oncology molecular diagnostic kits is seeking distribution opportunities to expand its market abroad

24.07.2020Published 182 days ago
Commercial
BOKR20200724001
Offers
With the cutting-edge platform technology, the Korean SME has been leading the molecular diagnostics market in Korea since 2013, based on PNA, Peptide Nucleic Acid. The company has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. PNA is an artificial DNA, or DNA/RNA analogue, which can be used to various applications and it has high potential to be applied as new therapeutics material, especially for oncology molecular diagnosis and mutation detection.

A Korean company, specialized in manufacturing Body Composition Analyzers (BCA) and Blood Pressure Monitors (BPM) seeks global distribution partners

23.07.2020Published 183 days ago
Commercial
BOKR20200723001
Offers
Since its foundation in 1993, the Korean company has been leading the domestic markets of blood pressure monitor and body composition analyzer for more than 20 years, with innovative technology in medical device manufacturing and software development by running its own R&D centre. The company has launched the company’s specialized brand of medical diagnostic products, which includes body composition analysers and automatic blood pressure monitors to secure competitiveness in the digital healthcare industry.

A Korean company seeks global distributors or manufacturers for a low-temperature gas plasma sterilizer and plasma surface treatment solution with an innovative plasma technology

20.07.2020Published 186 days ago
Commercial
BOKR20200708001
Offers
A technology-based start-up company that produces low-temperature plasma sterilizers for medical use is seeking distributor of medical equipment for product distribution and selling under licence agreement or manufacturing agreement as the company is willing to contribute to the international medical industry with its innovative products. Previously, almost a refrigerator-sized large sterilizer manufactured by major global companies had high demands. Thus, its application was quite limited to large hospitals.

A Korean company manufacturing ultra-fast COVID-19 diagnostic kits based on real-time PCR technology seeks distribution partners in Europe

20.07.2020Published 186 days ago
Commercial
BOKR20200719001
Offers
Due to its high contagiousness and severeness, rapid detection of the virus should be performed as quickly as possible for setting up timely quarantine measure as well as proper medication and treatment. A Korean company founded in 2010 is a biotech engineering company in South Korea specializes in molecular testing solutions to target multiplex on-site testing needs.

A leading biotech Korean company specialized in producing high-quality diagnostic kit for COVID-19 seeks for global partners

06.07.2020Published 200 days ago
Commercial
BOKR20200706001
Offers
Due to the novel coronavirus disease (COVID-19) spread worldwide, many countries are requesting Korean-made test kits for the coronavirus and its stable supply is important in a pandemic situation. Since its foundation in 1992, the Korean company specialized in molecular biology products and technologies have significantly contributed to the global health improvement from 2003.

A renowned Korean manufacturer of steam methane reformer for hydrogen refueling system is seeking carbon dioxide reduction technology under license agreement, JV agreement and research cooperation agreement

03.07.2020Published 203 days ago
Technology
TRKR20200628001
Requests
The hydrogen roadmaps issued by leading countries have contributed to the increase in the number of hydrogen-powered vehicles around the globe. However, although hydron is a carbon-free energy carrier, not everyone is convinced by hydrogen fuelled cars as for the fact that steam reforming process still causes massive emissions of greenhouse gases. This continues to register an unprecedented surge in demand for 100% environmentally-friendly ways of producing hydrogen which includes renewable energy utilization, development of carbon dioxide reduction technology etc.

A renowned Korean manufacturer for steam methane reformer for hydrogen refueling system or industrial hydrogen production bases is seeking for business partnerships under commercial agency agreement or distribution services agreement

28.06.2020Published 208 days ago
Commercial
BOKR20200628001
Offers
As climate change is recognized as a major issue in the global society, major countries around the world have started to move from carbon-focused industries to renewable and alternative energy industries to reduce greenhouse gas, a major cause of climate change.

A Korean company specialised in in-vitro diagnostics is looking for partners, interested in developing and licensing, commercialising aptamer immuno-PCR technology for in-vitro diagnostics of prostate cancer.

12.05.2020Published 255 days ago
Technology
TOKR20200506001
Offers
For the early diagnosis of prostate cancer, PSA (Prostate-Specific Antigen) test is primarily used. The test measures the level of PSA in a man’s blood by using ELISA. However, the PSA ELISA test has been reported to have low sensitivity and specificity. To overcome the limitation of conventional PSA ELISA test, the Korean company specialised in in-vitro diagnostics including Covid-19 real-time RT-PCT kit has developed the aptamer immuno-PCR technology.

A Korean company is looking for partner for their mobile negative pressure isolation room(NPIR) products under distribution services agreement

07.05.2020Published 260 days ago
Commercial
BOKR20200507001
Offers
The Covid-19 virus pandemic is increasing to over 200,000 casualties in 185 countries. However, the current lack of medical equipment is an urgent threat to cope with new suspected and confirmed patients. Many experts say that early detection through accurate testing and containment is a key measure to control the infection.

A Korean SME is seeking agents or distribution partners in the EU for their ethanol hand sanitizer gel effective against high and low pathogenic viruses

27.03.2020Published 301 days ago
Commercial
BOKR20200327001
Offers
Hygiene management is essential to protect against viruses. The Korean SME put patented substances in hand sanitizer with 62% of ethanol, which is common in the market. The company has also three patents, referring to the following contents: 1. Forms that are effective against highly pathogenic viruses 2. Forms that are effective on Low Pathogenic Viruses 3. Forms that are effective on the Swine Foot-and-mouth Disease Virus With these three patents, the Korean SME has produced their 62% ethanol hand sanitizer gel.

Stránky